Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


22.11.2021

1 Am J Gastroenterol
1 Am J Pathol
5 Anticancer Res
1 Biochem Biophys Res Commun
2 BMC Cancer
4 BMC Gastroenterol
1 Cancer
2 Cancer Res
3 Clin Res Hepatol Gastroenterol
4 Eur Radiol
1 Gut
5 Hepatology
2 Indian J Gastroenterol
1 Int J Cancer
10 J Hepatol
1 J Pediatr
2 Minerva Gastroenterol (Torino)
1 PLoS Comput Biol
15 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiology
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    PubMed         Abstract available


    Am J Pathol

  2. BATHULA CS, Chen J, Kumar R, Blackshear PJ, et al
    ZFP36L1 regulates Fgf21 mRNA turnover and modulates alcoholic hepatic steatosis and inflammation in mice.
    Am J Pathol. 2021 Nov 11. pii: S0002-9440(21)00478.
    PubMed         Abstract available


    Anticancer Res

  3. TSOCHANTARIDIS I, Voulgaridou GP, Giatromanolaki A, Koukourakis MI, et al
    Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres.
    Anticancer Res. 2021;41:5481-5488.
    PubMed         Abstract available

  4. TAGO T, Katsumata K, Udou R, Kasahara K, et al
    Significance of Radiofrequency Ablation for Unresectable Colorectal Cancer With Liver Metastases.
    Anticancer Res. 2021;41:5539-5547.
    PubMed         Abstract available

  5. FURUKAWA K, Onda S, Taniai T, Hamura R, et al
    Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases.
    Anticancer Res. 2021;41:5651-5656.
    PubMed         Abstract available

  6. ADACHI Y, Yamamura K, Yumoto S, Higashi T, et al
    Far-advanced Colorectal Liver Metastases Successfully Managed With Modified ALPPS and Radiofrequency Ablation in Combination With Chemotherapy.
    Anticancer Res. 2021;41:5855-5861.
    PubMed         Abstract available

  7. MASATSUNE S, Kimura K, Kashiwagi S, En W, et al
    Impact of Intraoperative Blood Loss and Blood Transfusion on the Prognosis of Colorectal Liver Metastasis Following Curative Resection.
    Anticancer Res. 2021;41:5617-5623.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  8. FANG J, Liang W
    ASCs -derived exosomes loaded with vitamin A and quercetin inhibit rapid senescence-like response after acute liver injury.
    Biochem Biophys Res Commun. 2021;572:125-130.
    PubMed         Abstract available


    BMC Cancer

  9. GEBAUER F, Damanakis AI, Popp F, Quaas A, et al
    Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surg
    BMC Cancer. 2021;21:1239.
    PubMed         Abstract available

  10. LIU X, Shan W, Li T, Gao X, et al
    Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/beta-catenin pathway in hepatocellular carcinoma.
    BMC Cancer. 2021;21:1224.
    PubMed         Abstract available


    BMC Gastroenterol

  11. WANG Y, Wu F, Chen C, Xu L, et al
    Soluble urokinase plasminogen activator receptor is associated with short-term mortality and enhanced reactive oxygen species production in acute-on-chronic liver failure.
    BMC Gastroenterol. 2021;21:429.
    PubMed         Abstract available

  12. MA D, Zeng J, Huang B, Yan F, et al
    Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adults.
    BMC Gastroenterol. 2021;21:431.
    PubMed         Abstract available

  13. SUN J, Guo H, Yu X, Zhu H, et al
    A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure.
    BMC Gastroenterol. 2021;21:422.
    PubMed         Abstract available

  14. LIU M, Chen J, Huang R, Huang J, et al
    Imaging features of intrahepatic cholangiocarcinoma mimicking a liver abscess: an analysis of 8 cases.
    BMC Gastroenterol. 2021;21:427.
    PubMed         Abstract available


    Cancer

  15. KATZENSTEIN HM, Malogolowkin MH, Krailo MD, Piao J, et al
    Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study.
    Cancer. 2021 Nov 11. doi: 10.1002/cncr.34014.
    PubMed         Abstract available


    Cancer Res

  16. PEASE DR, Fernandez-Zapico ME
    mTOR-Dependent ARID1A Degradation: A New Twist in the Genetic-Epigenetic Interplay Driving Hepatocellular Carcinoma.
    Cancer Res. 2021;81:5608-5610.
    PubMed         Abstract available

  17. REN X, Rong Z, Liu X, Gao J, et al
    The protein kinase activity of NME7 activates Wnt/beta-Catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma.
    Cancer Res. 2021 Nov 11. pii: 0008-5472.CAN-21-1020.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  18. OZCELIK F
    Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.
    Clin Res Hepatol Gastroenterol. 2021 Apr 27:101708.
    PubMed        

  19. FELLI E, Baumert T, Pessaux P
    Is minimally invasive true anatomical HCC resection a future way to improve results in bridge or salvage liver transplantation?
    Clin Res Hepatol Gastroenterol. 2020 Mar 18. pii: S2210-7401(20)30049.
    PubMed        

  20. RAZAQ S, Kara M, Ozcakar L
    Measure Grip Strength, Gait Speed and Quadriceps Muscle in Cirrhosis. Comment to "Frailty, sarcopenia and mortality in cirrhosis: What is the best assessment, how to interpret the data correctly and what interventions are possible?"
    Clin Res Hepatol Gastroenterol. 2021 Jun 1:101727.
    PubMed        


    Eur Radiol

  21. SCHEGERER AA, Frija G, Paulo G, Jaschke W, et al
    Radiation dose and diagnostic reference levels for four interventional radiology procedures: results of the prospective European multicenter survey EUCLID.
    Eur Radiol. 2021;31:9346-9360.
    PubMed         Abstract available

  22. YIN Y, Yakar D, Dierckx RAJO, Mouridsen KB, et al
    Liver fibrosis staging by deep learning: a visual-based explanation of diagnostic decisions of the model.
    Eur Radiol. 2021;31:9620-9627.
    PubMed         Abstract available

  23. LI M, Yang H, Liu Y, Zhang L, et al
    Comparison of the diagnostic performance of 2D and 3D MR elastography in staging liver fibrosis.
    Eur Radiol. 2021;31:9468-9478.
    PubMed         Abstract available

  24. GHANI MA, Fereydooni A, Chen E, Letzen B, et al
    Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
    Eur Radiol. 2021;31:8858-8867.
    PubMed         Abstract available


    Gut

  25. ARMANDI A, Schattenberg JM
    NAFLD between genes and environment: what drives fibrogenesis?
    Gut. 2021;70:815-816.
    PubMed        


    Hepatology

  26. YANG J, Ye J, Ma T, Tang F, et al
    TRIM11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome mediated degradation of PHLPP1.
    Hepatology. 2021 Nov 12. doi: 10.1002/hep.32234.
    PubMed         Abstract available

  27. TIAN L, Zhao L, Sze KM, Kam CS, et al
    Dysregulation of RalA signaling through dual regulatory mechanisms exerts its oncogenic functions in hepatocellular carcinoma.
    Hepatology. 2021 Nov 12. doi: 10.1002/hep.32236.
    PubMed         Abstract available

  28. KIM ER, Park JS, Kim JH, Oh JY, et al
    A GLP-1/GLP-2 receptor dual agonist to treat non-alcoholic steatohepatitis: targeting the gut-liver axis and microbiome.
    Hepatology. 2021 Nov 12. doi: 10.1002/hep.32235.
    PubMed         Abstract available

  29. LAEMMLE A, Poms M, Hsu B, Borsuk M, et al
    Aquaporin 9 Induction in Human iPSC-derived Hepatocytes Facilitates Modeling of Ornithine Transcarbamylase Deficiency.
    Hepatology. 2021 Nov 16. doi: 10.1002/hep.32247.
    PubMed         Abstract available

  30. KRAMER JR, Natarajan Y, Dai J, Yu X, et al
    Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease.
    Hepatology. 2021 Nov 15. doi: 10.1002/hep.32244.
    PubMed         Abstract available


    Indian J Gastroenterol

  31. PHILIPS CA, Agarwal M, Rajesh S, Ahamed R, et al
    A novel homozygous frameshift variant in the ABCC2-gene in Dubin-Johnson syndrome may predispose to chronic liver disease.
    Indian J Gastroenterol. 2021;40:72-76.
    PubMed         Abstract available

  32. PRIYADARSHI RN, Anand U, Kumar R, Thakur SK, et al
    Ischemic jejunal stricture in patients with extrahepatic portal vein obstruction.
    Indian J Gastroenterol. 2021;40:82-87.
    PubMed         Abstract available


    Int J Cancer

  33. RUTHERFORD MJ, Arnold M, Bardot A, Ferlay J, et al
    Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
    Int J Cancer. 2021;149:2020-2031.
    PubMed         Abstract available


    J Hepatol

  34. PAVLIDES M, Francis S, Barnes E
    Abbreviated MRI to screen for HCC in patients with cirrhosis. A step forward but a long road ahead.
    J Hepatol. 2021 Nov 8. pii: S0168-8278(21)02169.
    PubMed        

  35. HUO TI, Liao JI, Ho SY
    Prognostic prediction for patients with hepatocellular carcinoma receiving immunotherapy: Are we there yet?
    J Hepatol. 2021 Nov 12. pii: S0168-8278(21)02176.
    PubMed        

  36. TANTAI X, Liu Y, Yeo YH, Praktiknjo M, et al
    Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis.
    J Hepatol. 2021 Nov 13. pii: S0168-8278(21)02174.
    PubMed         Abstract available

  37. DING GY, Ma JQ, Yun JP, Chen X, et al
    Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma.
    J Hepatol. 2021 Nov 15. pii: S0168-8278(21)02178.
    PubMed         Abstract available

  38. SABOO K, Petrakov NV, Shamsaddini A, Fagan A, et al
    Stool microbiota are superior to saliva in distinguishing cirrhosis and hepatic encephalopathy using machine learning.
    J Hepatol. 2021 Nov 15. pii: S0168-8278(21)02183.
    PubMed         Abstract available

  39. D'AVOLA D, Granito A, de la Torre-Alaez M, Piscaglia F, et al
    The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma.
    J Hepatol. 2021 Nov 15. pii: S0168-8278(21)02185.
    PubMed         Abstract available

  40. LIU Y, Zhuo S, Zhou Y, Ma L, et al
    Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
    J Hepatol. 2021 Nov 15. pii: S0168-8278(21)02182.
    PubMed         Abstract available

  41. GULFO J, Rotondo F, de Leon CGA, Cornide-Petronio ME, et al
    FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats.
    J Hepatol. 2020 May 15. pii: S0168-8278(20)30299.
    PubMed         Abstract available

  42. DEEB M, Karlsen TH, Hirschfield GM
    The 6 C's of Primary Sclerosing Cholangitis.
    J Hepatol. 2020 Jul 7. pii: S0168-8278(20)30436.
    PubMed        

  43. LINE PD, Dueland S
    Liver transplantation for secondary liver tumors: the difficult balance between survival and recurrence.
    J Hepatol. 2020 Aug 17. pii: S0168-8278(20)30539.
    PubMed        


    J Pediatr

  44. GUO YM, Ge FL, Song HB, Xiong P, et al
    Relative Risk Analysis of Liver-related Adverse Drug Reactions in Children Based on China's National Spontaneous Reporting System.
    J Pediatr. 2021;234:85-91.
    PubMed         Abstract available


    Minerva Gastroenterol (Torino)

  45. BURRA P
    Management of complex liver diseases.
    Minerva Gastroenterol (Torino). 2021;67:2-3.
    PubMed        

  46. XU J, Liu K, Ma Z, Lin Y, et al
    Exploration of inflammation, oxidative stress, adiponectin and intestinal flora in patients with Hepatitis B, liver cirrhosis and hepatocellular carcinoma.
    Minerva Gastroenterol (Torino). 2021 Nov 18. pii: S2724-5985.21.03063.
    PubMed        


    PLoS Comput Biol

  47. ABEGAZ F, Martines AMF, Vieira-Lara MA, Rios-Morales M, et al
    Bistability in fatty-acid oxidation resulting from substrate inhibition.
    PLoS Comput Biol. 2021;17:e1009259.
    PubMed         Abstract available


    PLoS One

  48. TIYARATTANACHAI T, Apiparakoon T, Marukatat S, Sukcharoen S, et al
    Development and validation of artificial intelligence to detect and diagnose liver lesions from ultrasound images.
    PLoS One. 2021;16:e0252882.
    PubMed         Abstract available

  49. ROUNIS K, Makrakis D, Papadaki C, Monastirioti A, et al
    Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
    PLoS One. 2021;16:e0252537.
    PubMed         Abstract available

  50. JO HH, Min C, Kyoung DS, Park MA, et al
    Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study.
    PLoS One. 2021;16:e0253165.
    PubMed         Abstract available

  51. REIMER RP, Hokamp NG, Niehoff J, Zopfs D, et al
    Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma.
    PLoS One. 2021;16:e0252678.
    PubMed         Abstract available

  52. LEE JW, Hwang JS, Chung WJ, Lee HJ, et al
    Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.
    PLoS One. 2021;16:e0253886.
    PubMed         Abstract available

  53. SHIMIZU Y, Sasaki T, Takeshita JI, Watanabe M, et al
    Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
    PLoS One. 2021;16:e0253855.
    PubMed         Abstract available

  54. SHI X, Li J, Min B, Yang R, et al
    Application of ultrasound elastography for monitoring the effects of TbetaR1 shRNA therapy on hepatic fibrosis in a rat model.
    PLoS One. 2021;16:e0253150.
    PubMed         Abstract available

  55. SUKAHRI S, Mohamed Shah FZ, Ismail AI, Koshy M, et al
    Significantly higher atherosclerosis risks in patients with obstructive sleep apnea and non-alcoholic fatty liver disease.
    PLoS One. 2021;16:e0253298.
    PubMed         Abstract available

  56. STRUCK MF, Kliem P, Ebel S, Bauer A, et al
    Percutaneous hepatic melphalan perfusion: Single center experience of procedural characteristics, hemodynamic response, complications, and postoperative recovery.
    PLoS One. 2021;16:e0254817.
    PubMed         Abstract available

  57. WAQAR W, Asghar S, Manzoor S
    Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    PLoS One. 2021;16:e0256739.
    PubMed         Abstract available

  58. GAO L, Morine Y, Yamada S, Saito Y, et al
    Nrf2 signaling promotes cancer stemness, migration, and expression of ABC transporter genes in sorafenib-resistant hepatocellular carcinoma cells.
    PLoS One. 2021;16:e0256755.
    PubMed         Abstract available

  59. CHANG Y, Han JA, Kang SM, Jeong SW, et al
    Clinical impact of serum exosomal microRNA in liver fibrosis.
    PLoS One. 2021;16:e0255672.
    PubMed         Abstract available

  60. COUBARD OA, Ober KM, Gaumet M, Urbanski M, et al
    Standardization of the psychometric hepatic encephalopathy score in a French population.
    PLoS One. 2021;16:e0257136.
    PubMed         Abstract available

  61. WEN X, Wang S, Taveira TH, Akhlaghi F, et al
    Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH).
    PLoS One. 2021;16:e0251665.
    PubMed         Abstract available

  62. KHORPRASERT C, Thonglert K, Alisanant P, Amornwichet N, et al
    Advanced radiotherapy technique in hepatocellular carcinoma with portal vein thrombosis: Feasibility and clinical outcomes.
    PLoS One. 2021;16:e0257556.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  63. DARLYUK-SAADON I, Bai C, Heng CKM, Gilad N, et al
    Active p38alpha causes macrovesicular fatty liver in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Radiology

  64. VAN DER POL CB, McInnes MDF, Salameh JP, Levis B, et al
    CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
    Radiology. 2021 Nov 16:211244. doi: 10.1148/radiol.2021211244.
    PubMed         Abstract available


    Transplantation

  65. B N, J H, G L, A K, et al
    O-14: Portal Hypertensive Complications after Pediatric Combined Liver-intestine Transplantation from Late Vascular Compromise of Native Portacaval Shunt: Clinical Presentation and Management.
    Transplantation. 2021;105.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: